Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Clindamycin Phosphate Topical Solution (02483769). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Clindamycin HCL
20 general benefit · 2 not a benefit
Auro-Clindamycin · DIN 02436906 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Auro-Clindamycin · DIN 02436906
Manufacturer: Auro Pharma Inc.; listing date 2015-05-28
Daily cost (source): $1.7736
Health Canada: Marketed since 2015-03-02 · brand AURO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02436906)
Source record
DIN 02436906: Auro-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id AUR
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02436906
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92122
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: resolved shortage (ended August 30, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02436906
Shortage record checked October 6, 2026
Clindamycin · DIN 02400529 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Clindamycin · DIN 02400529
Manufacturer: Sanis Health Inc.; listing date 2022-04-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2022-02-11 · brand CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordClindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02400529)
Source record
DIN 02400529: Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id SAI
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02400529
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88532
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: resolved shortage (ended March 23, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02400529
Shortage record checked October 6, 2026
Jamp Clindamycin Capsules · DIN 02557878 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Clindamycin Capsules · DIN 02557878
Manufacturer: Jamp Pharma Corporation; listing date 2026-09-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2026-07-24 · brand JAMP CLINDAMYCIN CAPSULES · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Clindamycin Capsules: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02557878)
Source record
DIN 02557878: Jamp Clindamycin Capsules
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id JPC
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02557878
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106116
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02557878
Shortage record checked October 6, 2026
Jamp-Clindamycin · DIN 02483734 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp-Clindamycin · DIN 02483734
Manufacturer: Jamp Pharma Corporation; listing date 2019-10-31
Daily cost (source): $1.7736
Health Canada: Marketed since 2019-09-27 · brand JAMP CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02483734)
Source record
DIN 02483734: Jamp-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id JPC
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02483734
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97408
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: active shortage (reported September 15, 2026, estimated to end October 22, 2026, last updated September 23, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483734
Shortage record checked October 6, 2026
M-Clindamycin · DIN 02479923 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
M-Clindamycin · DIN 02479923
Manufacturer: Mantra Pharma Inc.; listing date 2021-09-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2019-05-28 · brand M-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Mantra pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordM-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02479923)
Source record
DIN 02479923: M-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id MAT
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02479923
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97049
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02479923
Shortage record checked October 6, 2026
Med-Clindamycin · DIN 02462656 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Med-Clindamycin · DIN 02462656
Manufacturer: Generic Medical Partners Inc.; listing date 2022-04-29
Daily cost (source): $1.7736
Health Canada: Marketed since 2021-12-22 · brand MED-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Generic medical partners inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMed-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02462656)
Source record
DIN 02462656: Med-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id GMP
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02462656
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95045
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02462656
Shortage record checked October 6, 2026
NRA-Clindamycin · DIN 02493748 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
NRA-Clindamycin · DIN 02493748
Manufacturer: Nora Pharma; listing date 2020-10-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2020-07-06 · brand NRA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Nora pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordNRA-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02493748)
Source record
DIN 02493748: NRA-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id NRA
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02493748
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98373
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02493748
Shortage record checked October 6, 2026
Teva-Clindamycin · DIN 02241709 · 150 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Clindamycin · DIN 02241709
Manufacturer: Teva Canada Limited; listing date 2000-11-30
Daily cost (source): $1.7736
Health Canada: Marketed since 2011-01-24 · brand TEVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02241709)
Source record
DIN 02241709: Teva-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id TEV
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02241709
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65371
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Shortage status: active shortage (reported October 8, 2025, last updated October 10, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241709
Shortage record checked October 6, 2026
Auro-Clindamycin · DIN 02436914 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Auro-Clindamycin · DIN 02436914
Manufacturer: Auro Pharma Inc.; listing date 2015-05-28
Health Canada: Marketed since 2015-03-02 · brand AURO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02436914)
Source record
DIN 02436914: Auro-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id AUR
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02436914
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92123
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02436914
Shortage record checked October 6, 2026
Clindamycin · DIN 02400537 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Clindamycin · DIN 02400537
Manufacturer: Sanis Health Inc.; listing date 2022-04-29
Health Canada: Marketed since 2022-02-11 · brand CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordClindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02400537)
Source record
DIN 02400537: Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id SAI
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02400537
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88533
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: resolved shortage (ended March 23, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02400537
Shortage record checked October 6, 2026
Jamp Clindamycin Capsules · DIN 02557886 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Clindamycin Capsules · DIN 02557886
Manufacturer: Jamp Pharma Corporation; listing date 2026-09-29
Health Canada: Marketed since 2026-07-24 · brand JAMP CLINDAMYCIN CAPSULES · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Clindamycin Capsules: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02557886)
Source record
DIN 02557886: Jamp Clindamycin Capsules
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id JPC
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02557886
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106117
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02557886
Shortage record checked October 6, 2026
Jamp-Clindamycin · DIN 02483742 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp-Clindamycin · DIN 02483742
Manufacturer: Jamp Pharma Corporation; listing date 2019-10-31
Health Canada: Marketed since 2019-09-27 · brand JAMP CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02483742)
Source record
DIN 02483742: Jamp-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id JPC
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02483742
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97409
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: active shortage (reported September 15, 2026, estimated to end October 22, 2026, last updated September 23, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483742
Shortage record checked October 6, 2026
M-Clindamycin · DIN 02479931 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
M-Clindamycin · DIN 02479931
Manufacturer: Mantra Pharma Inc.; listing date 2021-09-30
Health Canada: Marketed since 2019-05-28 · brand M-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Mantra pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordM-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02479931)
Source record
DIN 02479931: M-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id MAT
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02479931
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97050
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02479931
Shortage record checked October 6, 2026
Med-Clindamycin · DIN 02462664 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Med-Clindamycin · DIN 02462664
Manufacturer: Generic Medical Partners Inc.; listing date 2022-04-29
Health Canada: Marketed since 2021-12-22 · brand MED-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Generic medical partners inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMed-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02462664)
Source record
DIN 02462664: Med-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id GMP
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02462664
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95046
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02462664
Shortage record checked October 6, 2026
NRA-Clindamycin · DIN 02493756 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
NRA-Clindamycin · DIN 02493756
Manufacturer: Nora Pharma; listing date 2020-10-30
Health Canada: Marketed since 2020-07-06 · brand NRA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Nora pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordNRA-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02493756)
Source record
DIN 02493756: NRA-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id NRA
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02493756
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98374
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02493756
Shortage record checked October 6, 2026
Riva-Clindamycin · DIN 02468484 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Riva-Clindamycin · DIN 02468484
Manufacturer: Laboratoire Riva Inc.; listing date 2021-08-31
Health Canada: Marketed since 2017-10-13 · brand RIVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRiva-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02468484)
Source record
DIN 02468484: Riva-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id RIA
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02468484
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95691
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02468484
Shortage record checked October 6, 2026
Teva-Clindamycin · DIN 02241710 · 300 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Clindamycin · DIN 02241710
Manufacturer: Teva Canada Limited; listing date 2000-11-30
Health Canada: Marketed since 2011-01-24 · brand TEVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02241710)
Source record
DIN 02241710: Teva-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id TEV
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02241710
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65372
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Shortage status: shortage reported ended May 5, 2026 (report last updated May 5, 2026); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241710
Shortage record checked October 6, 2026
Riva-Clindamycin · DIN 02468476 · 150 mg · capsule
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Riva-Clindamycin · DIN 02468476
Manufacturer: Laboratoire Riva Inc.; listing date 2021-09-30
Daily cost (source): $1.7736
Health Canada: Dormant since 2025-07-22 · brand RIVA-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Laboratoire riva inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRiva-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02468476)
Source record
DIN 02468476: Riva-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id RIA
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02468476
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95690
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02468476
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since July 22, 2025 — choose a marketed DIN from the same-category list.
Apo-Clindamycin · DIN 02245232 · 150 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.Discontinued April 17, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Clindamycin · DIN 02245232
Manufacturer: Apotex Inc.; listing date 2002-07-29
Daily cost (source): $1.7736
Health Canada: Cancelled post market since 2025-04-17 · brand APO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Clindamycin: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2217). What the ministry pays, not the patient.
Ministry pays: $0.2217 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245232)
Source record
DIN 02245232: Apo-Clindamycin
Raw flags: sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id APX
Source form: Cap; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.2217; ministry $0.2217
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245232
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69247
Interchangeable products
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Dalacin C · DIN 00030570 · not recorded
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: discontinued (May 21, 2019, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245232
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 17, 2025 — choose a marketed DIN from the same-category list.
Apo-Clindamycin · DIN 02245233 · 300 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.Discontinued April 17, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-04-17 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Clindamycin · DIN 02245233
Manufacturer: Apotex Inc.; listing date 2002-07-29
Health Canada: Cancelled post market since 2025-04-17 · brand APO-CLINDAMYCIN · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Clindamycin: Formulary list price $0.44 per unit (the source does not state the unit; exact figure $0.4434). What the ministry pays, not the patient.
Ministry pays: $0.4434 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245233)
Source record
DIN 02245233: Apo-Clindamycin
Raw flags: sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id APX
Source form: Cap; strength: 300mg
Recorded listing: General benefit
Source prices (unrounded): $0.4434; ministry $0.4434
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245233
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69248
Interchangeable products
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Dalacin C · DIN 02182866 · not recorded
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: discontinued (July 12, 2019, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245233
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 17, 2025 — choose a marketed DIN from the same-category list.
Dalacin C · DIN 00030570 · 150 mg · capsule
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.Discontinued October 24, 2024 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Dalacin C · DIN 00030570
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Daily cost (source): $1.7736
Health Canada: Cancelled post market since 2024-10-24 · brand DALACIN C 150 MG · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150 MG · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordDalacin C: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00030570)
Source record
DIN 00030570: Dalacin C
Raw flags: notABenefit=Y, sec3=Y
Item: 081228006; group id 44; item number 0100; lccId None; manufacturer id PFI
Source form: Cap; strength: 150mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00030570
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=874
Interchangeable products
Apo-Clindamycin · DIN 02245232 · $0.2217
Auro-Clindamycin · DIN 02436906 · $0.2217
Clindamycin · DIN 02400529 · $0.2217
Jamp Clindamycin Capsules · DIN 02557878 · $0.2217
Jamp-Clindamycin · DIN 02483734 · $0.2217
M-Clindamycin · DIN 02479923 · $0.2217
Med-Clindamycin · DIN 02462656 · $0.2217
NRA-Clindamycin · DIN 02493748 · $0.2217
Riva-Clindamycin · DIN 02468476 · $0.2217
Teva-Clindamycin · DIN 02241709 · $0.2217
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00030570
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 24, 2024 — choose a marketed DIN from the same-category list.
Dalacin C · DIN 02182866 · 300 mg · capsule
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.Discontinued October 24, 2024 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2024-10-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Dalacin C · DIN 02182866
Manufacturer: Pfizer Canada Inc.; listing date 1996-12-19
Health Canada: Cancelled post market since 2024-10-24 · brand DALACIN C 300 MG · ATC J01FF01 CLINDAMYCIN · form Capsule · route Oral · ingredients CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 300 MG · company Pfizer canada ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordDalacin C: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02182866)
Source record
DIN 02182866: Dalacin C
Raw flags: notABenefit=Y, sec3=Y
Item: 081228088; group id 44; item number 0101; lccId None; manufacturer id PFI
Source form: Cap; strength: 300mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02182866
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19455
Interchangeable products
Apo-Clindamycin · DIN 02245233 · $0.4434
Auro-Clindamycin · DIN 02436914 · $0.4434
Clindamycin · DIN 02400537 · $0.4434
Jamp Clindamycin Capsules · DIN 02557886 · $0.4434
Jamp-Clindamycin · DIN 02483742 · $0.4434
M-Clindamycin · DIN 02479931 · $0.4434
Med-Clindamycin · DIN 02462664 · $0.4434
NRA-Clindamycin · DIN 02493756 · $0.4434
Riva-Clindamycin · DIN 02468484 · $0.4434
Teva-Clindamycin · DIN 02241710 · $0.4434
Shortage status: discontinued (October 29, 2024, reported by PFIZER CANADA ULC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02182866
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 24, 2024 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (D10AF): coverage varies; not interchangeable
- Benzoyl peroxide + clindamycin (Clindoxyl): general benefit
- Adapalene + benzoyl peroxide + clindamycin (Cabtreo): limited Use 724
Other drugs in the same formulary classes and how they are covered
Other drugs in the same formulary class (08:12:28 Other Antibiotics) and how they are covered
Matched class: 08:12:28 Other Antibiotics
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: CEFIXIME, CLINDAMYCIN PALMITATE
Some products covered without a code (check the product listing): CEFADROXIL, CEFPROZIL, CEFTRIAXONE DISODIUM, CEFUROXIME AXETIL, CEPHALEXIN MONOHYDRATE, TOBRAMYCIN, TOBRAMYCIN SULFATE
08:12:28 Other Antibiotics
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 500mg · Cap
· 4 products · General benefit · strengths: 20mg/mL, 400mg · Oral Susp, Tab
· 17 products · General benefit (11), Listed, not a benefit (6) · strengths: 125mg/5mL, 250mg/5mL, 250mg, 500mg · Oral Susp-100mL Pk, Oral Susp-75mL Pk, Tab
· 16 products · Listed, not a benefit (3), General benefit (9), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), Off-Formulary Interchangeable, not an ODB benefit (3) · strengths: 0.25g/Vial, 1g/Vial, 2g/Vial, 10g/Vial · Inj Pd-Vial Pk
· 9 products · General benefit (7), Listed, not a benefit (2) · strengths: 125mg/5mL, 250mg, 500mg · Susp, Tab
· 29 products · Listed, not a benefit (6), General benefit (23) · strengths: 250mg, 500mg, 25mg/mL, 50mg/mL · Cap, Pd for Oral Susp, Tab
· 1 products · General benefit · strengths: 15mg/mL · Pd for Oral Susp
· 3 products ·
Limited Use, codes 472 (1), General benefit (2) · strengths: 28mg, 300mg/5mL · Inh Pd-Cap, Inh Sol-5mL Pk
· 4 products · Listed, not a benefit (1), General benefit (3) · strengths: 80mg/2mL · Inj Sol-2mL Pk
· 1 products ·
Limited Use, codes 677 · strengths: 500mg/Vial · Pd for Sol (Preservative-Free)
· 1 products ·
Limited Use, codes 475 · strengths: 550mg · Tab
· 4 products ·
Limited Use, codes 557, 558, 559, 560 (2), Off-Formulary Interchangeable, not an ODB benefit (2) · strengths: 125mg, 250mg · Cap
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 08:12:28
and 3 more
Full class listing
Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:14:08 Azoles
Other drugs in the same formulary class (84:04:04 Antibiotics) and how they are covered
Matched class: 84:04:04 Antibiotics
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDE, FUSIDIC ACID, MUPIROCIN CALCIUM, SODIUM FUSIDATE
Some products covered without a code (check the product listing): MUPIROCIN
84:04:04 Antibiotics
· 4 products · General benefit · strengths: 1% & 5% · Gel, Top Gel
· 1 products ·
Limited Use, codes 724 · strengths: 1.2% w/w & 0.15% w/w & 3.1% w/w · Top Gel Pump
· 2 products · General benefit · strengths: 2% · Cr
· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Oint
· 1 products · General benefit · strengths: 2% w/w · Cr
· 2 products · General benefit · strengths: 2% · Oint
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:04
Full class listing
Related classes: 84:04:08 Fungicides, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives
Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: acne, bacterial endocarditis, bone and joint infections, gynecological infections, intra-abdominal infections, septicemia, skin and skin structure infections
From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
Covered without a code on the Ontario formulary: CLINDAMYCIN PALMITATE
CEFOXITIN SODIUM · Off-Formulary Interchangeable, not an ODB benefit
1 - Intra-abdominal infections such as peritonitis and intra-abdominal abscess
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
2 - Gynecological infections such as endometritis and pelvic cellulitis
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
3 - Septicemia
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
6 - Bone and joint infections caused by Staphylococcus aureus
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monograph
CEFTRIAXONE DISODIUM · Listed, not a benefit (3), General benefit (9), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1), Off-Formulary Interchangeable, not an ODB benefit (3)
• Skin and Skin Structure Infections caused by K. pneumoniae and species, P. mirabilis, Staph. aureus,
Staph. epidermidis and Streptococcus species (excluding enterococci).
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
• Bone and Joint Infections caused by Staph. aureus, Strep. pneumoniae and Streptococcus species
(excluding enterococci).
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
• Intra-Abdominal Infections caused by E.coli and K. pneumoniae.
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
CEFADROXIL · Listed, not a benefit (1), General benefit (3)
• Skin and skin structure infections caused by Staphylococcus aureus and/or Group A ß–
hemolytic streptococci.
PM: https://pdf.hres.ca/dpd_pm/00056563.PDF; date May 20, 2020; DIN 02235134; fetched 2026-09-10
Product monograph
CLINDAMYCIN PALMITATE · General benefit
DALACIN C FLAVOURED GRANULES is indicated for prophylaxis against alpha-hemolytic
(viridans group) streptococci before dental, oral and upper respiratory tract surgery.
a) The prophylaxis of bacterial endocarditis in patients allergic to penicillin with any of the
following conditions: congenital cardiac malformations, rheumatic and other acquired valvular
dysfunction, prosthetic heart valves, previous history of bacterial endocarditis, hypertrophic
cardiomyopathy, surgically constructed systemic-pulmonary shunts, mitral valve prolapse with
valvular regurgitation or mitral valve prolapse without regurgitation but associated with
thickening and/or redundancy of the valve leaflets.
b) Patients taking oral penicillin for prevention or recurrence of rheumatic fever should be given
another agent such as clindamycin, for prevention of bacterial endocarditis.
PM: https://pdf.hres.ca/dpd_pm/00085121.PDF; date 2026-06-23; DIN 00225851; fetched 2026-09-10
Product monograph
CLINDAMYCIN PHOSPHATE & ADAPALENE & BENZOYL PEROXIDE · Limited Use, codes 724
1 INDICATIONS
CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) is indicated for the
topical treatment of acne vulgaris in patients 12 years of age and older.
PM: https://pdf.hres.ca/dpd_pm/00076715.PDF; date AUG 14, 2024; DIN 02550423; fetched 2026-09-10
Product monograph
TAZAROTENE · Limited Use, codes 636
1 INDICATIONS
ARAZLO™ (tazarotene lotion), is indicated for:
• For the topical treatment of acne vulgaris in patients 10 years of age and older.
1.1 Pediatrics
Pediatrics (≥ 10 years of age)
The safety and efficacy of ARAZLO in pediatric patients (10 years of age and older) has been
established.
PM: https://pdf.hres.ca/dpd_pm/00082613.PDF; date NOV 28, 2025; DIN 02517868; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-09-22
Availability
Taro-Clindamycin · DIN 02266938
Shortage status: discontinued (2026-05-19, reported by TARO PHARMACEUTICALS INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02266938
Check this DIN againDalacin T 1% · DIN 00582301
Shortage status: active shortage (reported 2018-01-26, last updated 2019-03-11) — report may be stale, confirm; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00582301
Check this DIN againJamp-Clindamycin · DIN 02483734
Shortage status: active shortage (reported 2026-09-15, estimated to end 2026-10-22, last updated 2026-09-23); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483734
Check this DIN againTeva-Clindamycin · DIN 02241709
Shortage status: active shortage (reported 2025-10-08, last updated 2025-10-10); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241709
Check this DIN againJamp-Clindamycin · DIN 02483742
Shortage status: active shortage (reported 2026-09-15, estimated to end 2026-10-22, last updated 2026-09-23); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02483742
Check this DIN againTeva-Clindamycin · DIN 02241710
Shortage status: shortage reported ended 2026-05-05 (report last updated 2026-05-05); confirm supply with the pharmacy; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02241710
Check this DIN againApo-Clindamycin · DIN 02245232
Shortage status: discontinued (2019-05-21, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245232
Check this DIN againApo-Clindamycin · DIN 02245233
Shortage status: discontinued (2019-07-12, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245233
Check this DIN againDalacin C · DIN 02182866
Shortage status: discontinued (2024-10-29, reported by PFIZER CANADA ULC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02182866
Check this DIN again